ANNEXIN V BINDING DURING STORAGE OF PLATELET CONCENTRATE FROM BUFFY COAT, AFTER PATHOGEN REDUCTION TREATMENTS

被引：0
|
作者：
Castrillo Fernandez, A. [1 ]
Arcas Otero, C. [1 ]
Rodriguez Calvo, M., I [1 ]
机构：
[1] Ctr Transfus Galicia, Santiago De Compostela, Spain
来源：
VOX SANGUINIS | 2012年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：138 / 139
页数：2
相关论文
共 50 条
  • [1] Platelet cytoskeletal reorganization after obtention of platelet concentrates by the buffy coat method and during their storage
    Estebanell, E
    DiazRicart, M
    Lozano, M
    Mazzara, R
    Ordinas, A
    Castillo, R
    Escolar, G
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS316 - PS316
  • [2] In Vitro Evaluation of Platelet Concentrates from Buffy Coat Treated with Two Pathogen Reduction Technology (PRT)
    Castrillo Fernandez, A.
    Arcas Otero, C.
    Diaz Pereira, A.
    Rodriguez Calvo, M.
    TRANSFUSION, 2011, 51 : 54A - 54A
  • [3] Cytoskeletal reorganization after preparation of platelet concentrates, using the buffy coat method, and during their storage
    Estebanell, E
    Diaz-Ricart, M
    Lozano, M
    Mazzara, R
    Escolar, G
    Ordinas, A
    HAEMATOLOGICA, 1998, 83 (02) : 112 - 117
  • [4] Pathogen reduction treatment of buffy coat platelet concentrates in additive solution induces proapoptotic signaling
    Reid, Samantha
    Johnson, Lacey
    Woodland, Narelle
    Marks, Denese C.
    TRANSFUSION, 2012, 52 (10) : 2094 - 2103
  • [5] Nitric oxide levels increase during platelet concentrate production from buffy coats, but not during storage
    Feys, Hendrik B.
    Vandekerckhove, Philippe
    Compernolle, Veerle
    TRANSFUSION, 2013, 53 (01) : 233 - 234
  • [6] Preparation of buffy coat platelet hyperconcentrates treated with Mirasol® Pathogen Reduction Technology and stored in PAS
    de Korte, Dirk
    Marschner, S.
    Gouwerok, E.
    Vlaar, R.
    Goodrich, R.
    TRANSFUSION, 2008, 48 (02) : 154A - 154A
  • [7] Treatment of Buffy Coat Platelets in Platelet Additive Solution with the Mirasol® Pathogen Reduction Technology System
    Castrillo, Azucena
    Cardoso, Marcia
    Rouse, Lindsay
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2013, 40 (01) : 44 - 48
  • [8] Pathogen reduction treatment alters the immunomodulatory capacity of buffy coat- derived platelet concentrates
    Loh, Yen S.
    Johnson, Lacey
    Kwok, Matthew
    Marks, Denese C.
    TRANSFUSION, 2014, 54 (03) : 577 - 584
  • [9] Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products
    Li, J
    de Korte, D
    Woolum, MD
    Ruane, PH
    Keil, SD
    Lockerbie, O
    McLean, R
    Goodrich, RP
    VOX SANGUINIS, 2004, 87 (02) : 82 - 90
  • [10] Nitric oxide levels increase during platelet concentrate production from buffy coats, but not during storage Reply
    Park, Jiwon
    Piknova, Barbora
    Schechter, Alan N.
    TRANSFUSION, 2013, 53 (01) : 235 - 235
12345